Filter
3429
Text search:
National
Medicines
Policy
Featured
Recommendations
331
New Publications
976
Language
Document type
No document type
1791
Studies & Reports
646
Guidelines
474
Manuals
197
Strategic & Response Plan
181
Fact sheets
48
Training Material
45
Situation Updates
26
Brochures
6
Resource Platforms
6
Infographics
5
Online Courses
4
Countries / Regions
Global
167
India
132
Kenya
122
Uganda
93
South Africa
91
Ethiopia
83
Nigeria
71
Nepal
69
Western and Central Europe
68
Sierra Leone
67
Ghana
63
Liberia
62
Malawi
61
Africa
61
Myanmar / Burma
59
Zambia
55
Tanzania
54
Bangladesh
50
Latin America and the Carribbean
50
Ukraine
49
Namibia
46
Rwanda
40
Eastern Europe
33
Zimbabwe
29
South–East Asia Region
27
Asia
27
Philippines
23
Indonesia
21
Lesotho
21
Congo, Democratic Republic of
20
Syria
20
Cambodia
20
Mozambique
17
Botswana
15
East and Southern Africa
15
Guinea
14
Haiti
14
Senegal
13
Pakistan
13
West and Central Africa
13
Burkina Faso
12
Eswatini/ Swaziland
12
Yemen
12
Middle East and North Africa
12
Venezuela
11
Russia
11
Cameroon
10
South Sudan
10
Eastern Europe and Central Asia
10
Thailand
9
Sudan
9
Afghanistan
8
Brazil
8
Moldova
8
Somalia
7
Benin
7
Madagascar
7
Western Pacific Region
7
North America
7
Lebanon
6
Peru
6
Vietnam
6
Jordan
5
China
5
North Macedonia
5
Paraguay
5
Poland
5
Albania
5
Laos
5
Georgia
5
Iraq
4
Germany
4
Central African Republic
4
Hungary
4
Libya
4
Sri Lanka
4
Tajikistan
4
Morocco
3
Saudi Arabia
3
Egypt
3
Colombia
3
El Salvador
3
Bolivia
3
Mexico
3
Fiji
3
Bhutan
3
Palestine
3
Southern Africa
3
Timor Leste/ East Timor
3
Romania
3
Iran
3
Kyrgyzstan
3
Jamaica
3
Mauritius
3
Mali
2
Côte d’Ivoire / Ivory Coast
2
USA
2
Gambia
2
Papua New Guinea
2
Argentina
2
Serbia
2
Ecuador
2
Chile
2
Armenia
2
Canada
2
Qatar
2
Bulgaria
2
Gabon
2
Japan
2
Tunisia
2
United Kingdom
2
Belarus
2
Niger
1
Turkey
1
Chad
1
Dominican Republic
1
Switzerland
1
Burundi
1
Honduras
1
Greece
1
Guatemala
1
Nicaragua
1
Other region
1
Djibouti
1
Mongolia
1
Lithuania
1
Slovakia
1
Kazakhstan
1
Turkmenistan
1
Denmark
1
Maldives
1
Norway
1
Portugal
1
Israel
1
Latvia
1
Belize
1
Costa Rica
1
Panama
1
Authors & Publishers
Publication Years
Category
Countries
1416
Clinical Guidelines
294
Public Health
211
Women & Child Health
151
Key Resources
126
Capacity Building
39
Pharmacy & Technologies
38
Annual Report MEDBOX
1
Toolboxes
HIV
322
TB
246
AMR
210
COVID-19
194
Mental Health
179
Pharmacy
140
NCDs
88
Caregiver
87
Planetary Health
73
Disability
72
Malaria
71
NTDs
70
Conflict
66
Global Health Education
60
Ebola & Marburg
53
Health Financing Toolbox
50
Rapid Response
41
Refugee
40
Natural Hazards
20
2.0 Rapid Response
19
Polio
11
Zika
10
Specific Hazards
9
Cholera
5
Social Ethics
5
PQM conducted an assessment of the medicine quality assurance and quality control systems in Rwanda during November 9-13, 2009. Medicine quality assurance remains to be developed in Rwanda: the country has neither a medicine regulatory authority (MRA) nor a
...
Interagency Guidelines - This revised Interagency List of Essential Medicines for Reproductive Health presents
the current international consensus on rational selection of essential reproductive health m
...
The issue of Antimicrobial resistance has become one of the most substantial health issues, prompting the World Health Assembly (WHA) to urge Member States to finalise tailor made national action plans by May 2017, aligning them with objectives of t
...
Supportive supervision is considered critical to community health worker programme performance, but there is relatively little understanding of how it can be sustainably done at scale. Supportive supervision is a holistic concept that encompasses three key functions: management (ensuring performance
...
The attainment of Zambia’s goal of being a prosperous and middle-income country by 2030 as stipulated in its Vision 2030 is dependent on among others, a healthy and productive population. Therefore, the Government of the Republic of Zambia (GRZ) has prioritized health as a key socio-economic inves
...
The "Assessing National Capacity for the Prevention and Control of Noncommunicable Diseases: Report of the 2021 Global Survey" by WHO examines the global state of readiness and infrastructure for managing noncommunicable diseases (NCDs) across count
...
Implementation guide for national, district and facility levels.
This implementation guide contains practical guidance for policy-makers,
programme managers, health practitioners and other actors
...
Antimicrobial resistance (AMR) is occurring everywhere in the world, compromising the ability to treat infectious diseases, as well as undermining many other advances in health and medicine. Underlying factors that drive AMR include; weak or absent surveillance and monitoring systems, inadequate sys
...
This report reviews and analyses the Affordable Medicines Programme, which was introduced in Ukraine in April 2017 to provide patients with improved access to 23 outpatient medicines for the treatme
...
This document outlines Rwanda's policy on non-communicable diseases. The overall goal of NCDs Policy is to alleviate the burden of NCDs and their risk factors and protect Rwandan population from pre
...
This Implementation Kit (I-Kit), developed by the Health Communication Capacity Collaborative (HC3), helps national and local stakeholders to design country-specific social and behavioural change communication (SBCC) campaigns that address the threa
...
The WHO Model List of Essential Medicines and Model List of Essential Medicines for Children are updated and published every two years, intended as a guide for countries or regional authorities to a
...
The availability, prices and affordability of essential medicines in Malawi: A cross-sectional study
The Malawian government recently introduced cost-covering consultation fees for self-referral patients in tertiary public hospitals. Previously, patients received medicines free of charge in government-owned health facilities, but must pay elsewhere
...
In 2015, to advance the global and national response to antimicrobial resistance (AMR), the World Health Assembly issued resolution WHA68.7 calling for all Member States to develop AMR national acti
...
Antimicrobial resistance (AMR) is described as a situation when bacteria, viruses, fungi and parasites
change over time and no longer respond to medicines, making infections harder or impossible to treat,
and increasing the risk of disease spread,
...
Antimicrobial resistance (AMR) is a global human, animal, plant and environment health threat that needs to be addressed by every country. The impacts of AMR are wide-ranging in terms of human health, animal health, food security and safety, environmental effects on ecosystems and biodiversity, and
...
Recently, a renewed interest in large-scale community health worker (CHW) programs has been seen globally. This renewal provides an opportune moment to take stock of issues and challenges such programs face and what can be done to make them as effective as possible. With this in mind, this manual is
...
Cryptococcal disease, particularly cryptococcal meningitis is a significant cause of morbidity and mortality among people living with HIV with advanced HIV disease. It is estimated that it is responsible for nearly 19% of AIDS-related mortality, second only to tuberculosis. Rapid screening, diagnosi
...